Jean Mah

14PUBLICATIONS
73CO-AUTHORS
Molecular medicinePharmacogenomicsEnergy generation, conversion and storage (excl. chemical and electrical)Neurology and neuromuscular diseasesMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 15, 2026
Vamorolone Safety, Pharmacokinetics, and Exploratory Efficacy in Duchenne Muscular Dystrophy: A Phase II, Nonrandomized, Multiple-Dose Study in 2-<4-Year-Old Boys.

|Mar 03, 2026
Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy.

Hanns Lochmüller, Hernan Gonorazky, Elisa Nigro

|Oct 28, 2025
Patterns of Adherence to Lung Volume Recruitment Therapy Amongst Individuals With Duchenne Muscular Dystrophy: A Secondary Analysis of the STEADFAST Randomized Controlled Trial.

Naomi Dussah, Douglas A McKim, Jean K Mah

|May 13, 2025
Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen.

Guillaume Gauvreau, Tarannum Behlim, Pamela Ng

|Sep 23, 2024
Macrostructural Brain Abnormalities in Spinal Muscular Atrophy: A Case-Control Study.

Emilie Groulx-Boivin, Andrea Oliveira-Carneiro, Helen Carlson

|Feb 09, 2024
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.

Utkarsh J Dang, Jesse M Damsker, Michela Guglieri

Pageof 3

Frequent Collaborators

5 joint publications

Maryam Oskoui

5 joint publications

Hugh McMillan

3 joint publications

Elisa Nigro

3 joint publications

Eric P Hoffman